Stay updated on Pembrolizumab plus Vorinostat in Head and Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab plus Vorinostat in Head and Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab plus Vorinostat in Head and Neck Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Footer now shows Revision: v3.5.2, replacing Revision: v3.5.0. This is a technical update with no impact on study information or user actions.
    Difference
    0.1%
    Check dated 2026-04-16T10:58:22.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Added 'Squamous cell carcinoma of the head and neck' as a listed condition in the study details.
    Difference
    0.1%
    Check dated 2026-04-02T04:47:37.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Revision v3.5.0 added; revision v3.4.3 removed.
    Difference
    0.1%
    Check dated 2026-03-18T17:52:23.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T16:59:02.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; removed the government funding lapse notice and the older Revision: v3.4.1 entry.
    Difference
    0.4%
    Check dated 2026-02-11T10:15:50.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    The page now displays a government funding lapse notice and the site version was updated to Revision: v3.4.1, which are administrative updates and do not affect core study content or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T06:46:40.000Z thumbnail image

Stay in the know with updates to Pembrolizumab plus Vorinostat in Head and Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab plus Vorinostat in Head and Neck Cancer Clinical Trial page.